Salivary resistin level and its association with insulin resistance in obese individuals

Table 1 Salivary resistin concentration in association with body mass index and the homeostatic model assessment of insulin resistance

Study group	BMI (kg/m2)	Salivary resistin (ng/mL)	Correlation with BMI	Correlation with blood glucose	Correlation with HOMA-IR	Correlation test used	Ref.
Healthy	22.39 ± 3.65	1.69	NS	-	-	Partial correlation	Mamali et al[77]
T2DM	25.5 ± 4.9	3.4± 0.41	-0.391	-0.14	-0.201	Pearson’s test	Yin et al[29]
Control	23.9 ± 3.3	1.5 ± 0.3	-0.17	-0.281	-0.19
T2DM	-	4 ± 0.451	-	-	-	-	Sarhat et al[80]
Control	-	1.73 ± 0.34	-	-	-	-
Obese diabetic	34.3 ± 3.9	14.7 ± 2.8	Significant	NS			Al-Rawi and Al-Marzooq[81]
Obese non-diabetic	34.2 ± 2.9	14.4 ± 3.6	Significant
Control “Non-obese-non -diabetic	7.1 ± 2.1	10.8 ± 6.1	Significant		-
T2DM	-	9.2 ± 2.31	-	-	-		Srinivasan et al[82]
Control	-	5.7 ± 1.3	-	-	-
GDM	32 (20.4–43.7)	13.11	-	-	-		Gürlek and Çolak[83]
Control	27.2 (19.4–42)	5.9	-	-	-

¹Significant difference between the study groups, significant correlation. BMI: Body mass index; HOMA-IR: Homeostatic model assessment of insulin resistance; NS: Not significant; T2DM: Type 2 diabetes mellitus; GDM: Gestational diabetes mellitus.